WallStSmart

Nice Ltd ADR (NICE)vsSynopsys Inc (SNPS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Synopsys Inc generates 172% more annual revenue ($8.01B vs $2.95B). NICE leads profitability with a 20.8% profit margin vs 13.8%. NICE appears more attractively valued with a PEG of 0.86. NICE earns a higher WallStSmart Score of 78/100 (B+).

NICE

Strong Buy

78

out of 100

Grade: B+

Growth: 8.0Profit: 7.5Value: 9.3Quality: 7.5
Piotroski: 4/9Altman Z: 3.23

SNPS

Hold

47

out of 100

Grade: D+

Growth: 6.7Profit: 5.0Value: 3.0Quality: 4.5
Piotroski: 1/9Altman Z: 1.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NICEUndervalued (+45.3%)

Margin of Safety

+45.3%

Fair Value

$202.91

Current Price

$101.87

$101.04 discount

UndervaluedFair: $202.91Overvalued

Intrinsic value data unavailable for SNPS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NICE6 strengths · Avg: 9.5/10
P/E RatioValuation
10.5x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
56.7%10/10

Earnings expanding 56.7% YoY

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.2310/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
20.8%9/10

Keeps 21 of every $100 in revenue as profit

PEG RatioValuation
0.868/10

Growing faster than its price suggests

SNPS2 strengths · Avg: 9.5/10
Revenue GrowthGrowth
65.5%10/10

Revenue surging 65.5% year-over-year

Market CapQuality
$92.45B9/10

Large-cap with strong market position

Areas to Watch

NICE1 concerns · Avg: 2.0/10
Price/BookValuation
39.6x2/10

Trading at 39.6x book value

SNPS4 concerns · Avg: 2.5/10
Return on EquityProfitability
5.5%3/10

ROE of 5.5% — below average capital efficiency

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
3.172/10

Expensive relative to growth rate

P/E RatioValuation
74.3x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : NICE

The strongest argument for NICE centers on P/E Ratio, EPS Growth, Debt/Equity. Profitability is solid with margins at 20.8% and operating margin at 22.4%. PEG of 0.86 suggests the stock is reasonably priced for its growth.

Bull Case : SNPS

The strongest argument for SNPS centers on Revenue Growth, Market Cap. Revenue growth of 65.5% demonstrates continued momentum.

Bear Case : NICE

The primary concerns for NICE are Price/Book.

Bear Case : SNPS

The primary concerns for SNPS are Return on Equity, Piotroski F-Score, PEG Ratio. A P/E of 74.3x leaves little room for execution misses.

Key Dynamics to Monitor

NICE profiles as a mature stock while SNPS is a growth play — different risk/reward profiles.

SNPS carries more volatility with a beta of 1.15 — expect wider price swings.

SNPS is growing revenue faster at 65.5% — sustainability is the question.

SNPS generates stronger free cash flow (822M), providing more financial flexibility.

Bottom Line

NICE scores higher overall (78/100 vs 47/100), backed by strong 20.8% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nice Ltd ADR

TECHNOLOGY · SOFTWARE - APPLICATION · USA

NICE Ltd. provides business software solutions globally. The company is headquartered in Ra'anana, Israel.

Visit Website →

Synopsys Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Synopsys is an American electronic design automation company that focuses on silicon design and verification, silicon intellectual property and software security and quality. Products include logic synthesis, behavioral synthesis, place and route, static timing analysis, formal verification, hardware description language (SystemC, SystemVerilog/Verilog, VHDL) simulators, and transistor-level circuit simulation.

Visit Website →

Want to dig deeper into these stocks?